[Chronic heart failure--suggestion to a management program].
In 1994, a Norwegian programme for diagnosis and treatment of chronic heart failure was published. Recently the American College of Cardiology, the American Heart Association and the Task Force on Heart Failure of the European Society of Cardiology have published similar guidelines. In this article, the Working Group on Heart Failure of the Norwegian Society of Cardiology presents an updated programme for evaluation and management of patients with chronic heart failure.
Westheim
A
A
Hjertemedisinsk avdeling, Ullevål sykehus, Oslo.
Dickstein
K
K
Gundersen
T
T
Hole
T
T
Kjekshus
J
J
Myhre
E S
ES
Rønnevik
P K
PK
Samstad
S
S
Smith
P
P
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D017408:Guidelines as Topic; D006333:Heart Failure / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D009664:Norway; D012041:Regional Medical Programs; D012955:Societies, Medical; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000924:Anticholesteremic Agents; D000925:Anticoagulants; D004071:Digitalis Glycosides; D004232:Diuretics; D014665:Vasodilator Agents